Claims for Patent: 4,818,538

Summary for Patent: 4,818,538

Title:	Treatment of human viral infections
Abstract:	Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof. Also disclosed is the use of the 5.dbd.-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.
Inventor(s):	Rideout; Janet L. (Raleigh, NC), Barry; David W. (Chapel Hill, NC), Lehrman; Sandra N. (Durham, NC), St. Clair; Martha H. (Durham, NC), Furman; Phillip A. (Durham, NC)
Assignee:	Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:	07/111,205
Patent Claims:	1. A sealed container including a pharmaceutical composition in unit dosage form comprising 5 to 500 mg of 3'-azido-3'-deoxythymidine together with a pharmaceutically acceptable solid carrier. 2. A dose of a pharmaceutical composition comprising 5 to 500 mg of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable liquid carrier. 3. A sealed contaner containing a sterile pharmaceutical composition for parenteral administration including a pharmaceutically acceptable liquid carrier and the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof. 4. A pharmaceutical composition in unit dosage form comprising per dosage unit 5 to 500 mg of a pharmaceutically acceptable salt of 3'-azido-3'-deoxythymidine together with a pharmaceutically acceptable carrier in solid or liquid form. 5. A pharmaceutical composition in unit dosage form comprising per dosage unit 5 to 500 mg of the 5'-monophosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier in solid or liquid form. 6. A pharmaceutical composition in unit dosage form comprising per dosage unit 5 to 500 mg of the 5'-diphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier in solid or liquid form. 7. A pharmaceutical composition in unit dosage form comprising per dosage unit 5 to 500 mg of the 5'-triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier in solid or liquid form. 8. The composition of claim 2, 4, 5, 6 or 7 in the form of a suspension. 9. The composition of claim 1, 4, 5, 6 or 7 in the form of a suppository.